Yokoyama-Yasunaka JKU - Search Results

1

New iminodibenzyl derivatives with anti-leishmanial activity.

Arndt A, Liria CW, Yokoyama-Yasunaka JKU, Machini MT, Uliana SRB, Espósito BP. Arndt A, et al. Among authors: yokoyama yasunaka jku. J Inorg Biochem. 2017 Jul;172:9-15. doi: 10.1016/j.jinorgbio.2017.04.004. Epub 2017 Apr 4. J Inorg Biochem. 2017. PMID: 28414928

2

Synthesis, characterization and evaluation of antileishmanial activity of copper(II) with fluorinated α-hydroxycarboxylate ligands.

da Silva Maffei R, Yokoyama-Yasunaka JK, Miguel DC, Uliana SR, Espósito BP. da Silva Maffei R, et al. Biometals. 2009 Dec;22(6):1095-101. doi: 10.1007/s10534-009-9260-1. Biometals. 2009. PMID: 19680603

3

Increasing the activity of copper(II) complexes against Leishmania through lipophilicity and pro-oxidant ability.

Portas Ados S, Miguel DC, Yokoyama-Yasunaka JK, Uliana SR, Espósito BP. Portas Ados S, et al. J Biol Inorg Chem. 2012 Jan;17(1):107-12. doi: 10.1007/s00775-011-0834-3. Epub 2011 Aug 25. J Biol Inorg Chem. 2012. PMID: 21866394

4

Leishmania is not prone to develop resistance to tamoxifen.

Coelho AC, Trinconi CT, Senra L, Yokoyama-Yasunaka JK, Uliana SR. Coelho AC, et al. Int J Parasitol Drugs Drug Resist. 2015 Jun 17;5(3):77-83. doi: 10.1016/j.ijpddr.2015.05.006. eCollection 2015 Dec. Int J Parasitol Drugs Drug Resist. 2015. PMID: 26150922 Free PMC article.

5

Topical tamoxifen in the therapy of cutaneous leishmaniasis.

Trinconi CT, Reimão JQ, Bonano VI, Espada CR, Miguel DC, Yokoyama-Yasunaka JKU, Uliana SRB. Trinconi CT, et al. Among authors: yokoyama yasunaka jku. Parasitology. 2018 Apr;145(4):490-496. doi: 10.1017/S0031182017000130. Epub 2017 Mar 9. Parasitology. 2018. PMID: 28274283

6

Tamoxifen as a potential antileishmanial agent: efficacy in the treatment of Leishmania braziliensis and Leishmania chagasi infections.

Miguel DC, Zauli-Nascimento RC, Yokoyama-Yasunaka JK, Katz S, Barbiéri CL, Uliana SR. Miguel DC, et al. J Antimicrob Chemother. 2009 Feb;63(2):365-8. doi: 10.1093/jac/dkn509. Epub 2008 Dec 17. J Antimicrob Chemother. 2009. PMID: 19095684

7

Inhibitory activity of limonene against Leishmania parasites in vitro and in vivo.

Arruda DC, Miguel DC, Yokoyama-Yasunaka JK, Katzin AM, Uliana SR. Arruda DC, et al. Biomed Pharmacother. 2009 Nov;63(9):643-9. doi: 10.1016/j.biopha.2009.02.004. Epub 2009 Mar 10. Biomed Pharmacother. 2009. PMID: 19321295

8

Parasite burden in Leishmania (Leishmania) amazonensis-infected mice: validation of luciferase as a quantitative tool.

Reimão JQ, Trinconi CT, Yokoyama-Yasunaka JK, Miguel DC, Kalil SP, Uliana SR. Reimão JQ, et al. J Microbiol Methods. 2013 May;93(2):95-101. doi: 10.1016/j.mimet.2013.02.007. Epub 2013 Mar 4. J Microbiol Methods. 2013. PMID: 23466934

9

Discovery of synthetic Leishmania inhibitors by screening of a 2-arylbenzothiophene library.

Bonano VI, Yokoyama-Yasunaka JK, Miguel DC, Jones SA, Dodge JA, Uliana SR. Bonano VI, et al. Chem Biol Drug Des. 2014 Mar;83(3):289-96. doi: 10.1111/cbdd.12239. Epub 2013 Dec 26. Chem Biol Drug Des. 2014. PMID: 24119198

10

Combination therapy with tamoxifen and amphotericin B in experimental cutaneous leishmaniasis.

Trinconi CT, Reimão JQ, Yokoyama-Yasunaka JK, Miguel DC, Uliana SR. Trinconi CT, et al. Antimicrob Agents Chemother. 2014 May;58(5):2608-13. doi: 10.1128/AAC.01315-13. Epub 2014 Feb 18. Antimicrob Agents Chemother. 2014. PMID: 24550333 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

25 results

Search Page